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Summary Leucocyte interactions with the cremaster muscle microcirculation in vivo were investigated in response to culture medium
conditioned with different cell types in 25 adult male Swiss mice. Animals were divided into five groups. Three groups received ex vivo
fluorescently labelled lymphokine activated killer (LAK) cells systemically and had either tumour (murine melanoma K1735)-conditioned
medium (TCM), fibroblast (murine 3T3)-conditioned medium (FCM) or fresh culture medium administered topically to the cremaster muscle.
In the two remaining groups, the host leucocytes were labelled fluorescently by systemic administration of acridine red, and either TCM or
FCM was applied topically to the cremaster muscle. There was an immediate but transient increase in the frequency of rolling and adherent
LAK cells, and a subsequent (90-120 min later) increase in rolling and adherent host leucocytes, demonstrating temporal differences in the
response to topical administration of TCM. These increases in contact with the vascular endothelium occurred in all vessel types, venules,
arterioles and capillaries, with the greatest response observed in the venules. The FCM and normal culture medium did not affect the
distribution and localization of either LAK cells or host leucocytes. These data suggest that there are one or more soluble tumour-specific
chemoattractants for leucocytes present in the conditioned medium. The mouse cremaster muscle microcirculation is therefore a useful
model to investigate the mechanism of leucocyte-endothelium interactions in tumour biology.
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Adoptive immunotherapy using cytokines alone or in combination
with lymphokine activated killer (LAK) cells has been demon-
strated to produce tumour necrosis and a dramatic reduction in the
number of metastases in a variety of animal models (Lafreniere
and Rosenberg, 1985; Ettinghausen and Rosenberg, 1986;
Rosenberg et al, 1987; Schwarz et al, 1989). The clinical use of
adoptive immunotherapy has been successful in the treatment of
some advanced cancers, in particular malignant melanoma and
renal cell carcinoma, with 20-30% ofpatients showing a complete
or partial tumour regression (Rosenberg and Lotze, 1986;
Rosenberg et al, 1987; Hayat et al, 1991). Lymphocyte migration
via the host microcirculation to the site ofthe tumouris aprerequi-
site for a therapeutic response. Systemic administration of rh-IL2
alone (Rosenberg et al, 1987) or in combination with LAK cells
stimulates in vivo proliferation of LAK cells in the lungs of mice
and promotes tumour regression (Ettinghausen et al, 1985). The
limited numbers of patients responding to this therapy and the
potentially serious side-effects of high-dose cytokine therapy
highlights the need to perform preclinical studies in vitro and in
vivo. Moreover, an increased understanding of the mechanisms
involved in LAK cell-induced anti-cancer responses will allow
improved efficacy ofthis therapeutic approach.
Until recently, it has been difficult to assess accurately the
migration and behaviour ofadoptively transferred effector cells in
vivo. Initial studies of leucocyte and tumour cell migration used
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radiolabelled effector cells and removal ofthe organ at a specified
time after cell administration. Although these studies demon-
strated increased migration of cells into liver and spleen, it was
thought to be due to non-specific uptake ofreleased radiolabel into
the organ (Wiltrout et al, 1983; Basse et al, 1990). These studies
allowed quantification of cell migration but provided no dynamic
information on cell behaviour in vivo. However, fluorescent dyes
are now available for direct visualization of injected effector
cells, allowing more accurate estimation of the cell distribution
into tissues.
Basse and his colleagues (1992) compared cell migration
following the administration of radiolabelled and fluorescently
labelled adherent LAK (A-LAK) cells in vivo. Cell migration
using these two methods was then assessed by either counting
radioactivity or the number offluorescent cells using frozen tissue
sections and fluorescence microscopy. They concluded that fluo-
rescently labelling cells gave a more realistic index of A-LAK
migration than radiolabelling cells. Again, this study provided
valuable information on cell distribution and migration but no
dynamic information on cell behaviour in vivo.
The technique ofin vivo microscopy permits dynamic visualiza-
tion ofthe microcirculation (Reed et al, 1989; Brown et al, 1994a)
and ofthe ex vivo fluorescently labelled LAK cells and host leuco-
cytes moving through the microcirculation, migrating across the
endothelium and basement membrane and localizing within the
tumour (Sasaki et al, 1991; Brown et al, 1994b). This is therefore
an effective method for monitoring cell trafficking in vivo.
The mechanism by which immune cells (host and activated
lymphocytes) are initially attracted to the tumour site is not fully
understood. They may gain access to the tumour via the microcir-
culation simply as circulating immune cells, or may be attracted to
993994 NJBrown andMWR Reed
specific antigens expressed on tumour cells or endothelial cells, or
may respond to chemoattractant agents released from within the
tumour environment, such as chemokines and cytokines, which
may increase the number ofcells homing towards the tumour site.
The aim of this study is therefore to determine whether tumour
cells produce soluble factors that attract increased numbers ofLAK
cells and/orhostleucocytes to the mouse cremaster muscle microcir-
culation in vivo and induce alterations in the frequency of leuco-
cyte-endothelium interactions. This was investigated by topical
application oftumour-conditioned medium (TCM) from the murine
melanoma cell line K1735 orfibroblast-conditioned medium (FCM)
from the murine fibroblast cell line 3T3. The study also aims to
determine whether this model may be useful in future experiments
investigating the mechanism ofleucocyte-endothelium interactions.
MATERIALS AND METHODS
Animals
Experiments were performed on 8-week-old male Swiss mice
obtained from Sheffield Field Laboratories and weighing between
15 and 25 g. All experiments were approved by the Home Office
and performed within Project Licence Number PPL 50/0695.
Culture medium
Culture medium (CM) consisted of RPMI-1640 supplemented
with 10% fetal calf serum (FCS), 100 U ml-' penicillin, 100 [ig
ml-' streptomycin and 2 mM L-glutamine (all obtained from Gibco,
Paisley, UK). This is known as complete culture medium. LAK
medium consisted of complete medium to which 5 x 10-5 M 2-
mercaptoethanol (BDH Chemicals, UK) was also added. Human
recombinant interleukin 2 (IL-2) was provided by Glaxo, UK
(Wadhwa et al, 1993).
Preparation of LAK cells
The spleen was removed aseptically from a mouse, placed in a Petri
dish, minced with a scalpel blade and then crushed with the butt of
a 50-ml syringe. Cold phosphate-buffered saline (PBS) was added
and the mixture passed through a nylon wool gauze. The filtrate
(20 ml) was layered onto Lymphoprep (10 ml) and centrifuged at
2100 r.p.m. for 30 min. The white cells, which formed a band at the
interface, werecollected,diluted withcomplete media (25 ml) at4°C
and spun at 2100r.p.m. for afurther 15 min. The resultant cell pellet
was washedtwice more with coldcomplete mediaandcentrifuged at
2100 r.p.m. for 10 min. The cells were then resuspended in LAK
media at a concentration of 2 x 106 cells ml-'. Cells were placed in
a 24-well flat-bottomed tissue culture plate, 1 ml per well. IL-2
(1000 U ml-') was added to each well and the plates cultured for 4
days at 37°C and5% carbon dioxide and95% airtoinducecells with
LAK-like activity. Cells were then removed from the wells, washed
twice andresuspended incomplete mediatobefluorescently labelled
for the in vivo microscopy experiments or to use in the cytotoxicity
assays. LAK cells are large granular lymphocytes, with 95-100%
expressing anatural killer (NK) cell phenotype.
Fluorescent labelling of LAK cells
LAK cells (5 x 106 m-') were incubated for 15 min at 370C with
the fluorochrome acridine red (500 [tg ml-'). The cells were then
washedtwice withcomplete medium andresuspended in complete
medium at a final concentration of 10 x 106 ml'-.
Cytotoxicity assays
(1) Effectorcells
LAK cells were prepared from murine spleen as described previ-
ously and suspended in media at a concentration of 2 x 106 cells
ml-'. A 100-pl aliquot of effector cell suspension was serially
diluted across a 96-well plate to give effector-target cell ratios of
between 50:1 and 3:1. Wells were prepared in triplicate.
(2) Targetcells
The LAK cell-resistant but natural killer (NK) cell-sensitive target
cell-line P815,achemically induced mastocytoma inDBA/2 mice,
YACI and the murine melanoma cell line K1735 were maintained
in complete culture medium. Cells were always passaged one
day before the cytotoxicity assay, and cells were harvested from
logarithmically growing cultures.
(3) Experimentalprotocol
Cell aliquots (10 ml) were centrifuged at 1300 r.p.m. and the pellet
was resuspended in media. 3.7 MBq of Na5'CrO4 (Amersham,
UK) was incubated with the cells for 1 h at 37°C. Cells were then
washed, resuspended in 10 ml of fresh media and incubated for a
further hour. Cells were then washed again and resuspended in
media to a final concentration of 105 cells ml-'. A 100-tl aliquotof
the target cell suspension was added to each well ofthe microassay
plate containing the effectors. The plate was incubated for 4 h at
37°C and 5% carbon dioxide. At the end ofthis period, the super-
natant was removed from each well, placed in an adjacent empty
well and left to dry overnight. The radioactivity (c.p.m.) of each
well was then counted using a gamma spectrophotometer. The
percentage chromium release and cytotoxicity were calculated
from the following equations:
Release (%) = 2 xc.pm.supematant
c.p.m. supernatant +c.p.m.cells
Cytotoxicity (%) = testrelease(%)
-spontaneousrelease(%)
100 -spontaneous release (%)
Preparation of conditioned medium
The murine melanoma cell line K1735 and murine 3T3 fibroblasts
were maintained in Dulbecco's culture medium supplemented with
10% FCS and 2 mM L-glutamine. The medium was then changed
and the cells maintained in serum-free Dulbecco's culture medium
supplemented with L-glutamine. After 24 h, when all cell lines
were in exponential growth phase, the medium was removed from
the melanoma cells, tumour-conditioned medium (TCM) and from
the 3T3 fibroblasts, fibroblast-conditioned medium (FCM) and
stored as frozen aliquots (100 [tl) to use in the in vivo microscopy
experiments. The pH ofthe culture media was 7.2-7.4.
Surgical procedure
Animals were anaesthetized with an intraperitoneal injection of
diazepam (0.5 mg ml-', Dumex) and Hypnorm (fentanyl citrate
0.0315 mg ml-1 and fluanisone 1 mg ml-',Janssen Pharmaceutical)
in the ratio of 1:1 at a volume of 0.1 ml per 100 g body weight,
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with supplementation as required to maintain adequate anaesthesia
and analgesia.
A midline incision was made in the neck and a tracheostomy
performed. A portex tracheostomy cannula was inserted and
secured with a suture. This preserved the airway and allowed the
aspiration of secretions from the bronchial tree during the experi-
ment if required. The left carotid artery was cannulated and
connected to a pressure transducer and physiograph (Micro-Med,
Louisville, USA) to monitor mean arterial blood pressure and
heart rate. The cannula also provided access for the administration
of fluorescently labelled cells. An oesophageal thermistor probe
was inserted and connected to a thermometer (Fluke, Washington,
USA). The animal was then placed on a warming pad to maintain
body temperature (35-37°C). A further thermistor was placed
between the animal and the warming pad to prevent overheating.
The fur on the right side of the scrotum was moistened and the
scrotal skin incised in the ventral midline starting at the tip of the
scrotum. The underlying intact cremaster was gently dissected
from the surrounding connective tissue and the fascia covering the
muscle carefully removed. A stay suture (5/0 silk) was placed in
the apex of the cremaster. The mouse was then transferred to a
perspex animal board with a glass microscope slide mounted on
perspex pegs. The rear legs ofthe animal were secured under trac-
tion around the pegs and the testis and cremaster positioned on the
microscope slide. The muscle was held in place by the stay suture
and electrocautery was used to open the cremaster along a rela-
tively avascularplane in the ventral midline. Care was taken not to
damage the underlying testis. The cremaster was spread flat and
held by four more stay sutures positioned around the circumfer-
ence of the cremaster. The dorsal connective tissue ligament
between the testis and the cremaster was divided using cautery and
the testis gently returned to the abdominal cavity. Throughout the
surgical procedure the tissues were kept moist with warm saline.
The cremaster muscle preparation with intact neurovascular
supply was then covered with an impermeable membrane to
prevent dehydration.
In vivo microscopy
The animal, warming pad and perspex board were transferred to
the stage of a Nikon fluorescent microscope (Orthophot) equipped
with a tungsten lamp for transmitted light microscopy and a
mercury arc lamp for epi-illumination fluorescent light micro-
scopy. A filter cube interposed into the light path of the mercury
arc lamp permitted green (490-530 nm) light to be selected forepi-
illumination. Images of the preparation were monitored using a
silicon-intensified tube camera (SIT, Hamamatsu Phototonics,
UK), displayed on a high-resolution monitor (Sony PVM-1443)
and recorded on video (Sony SLV-373-UB) tape for later off-line
analysis.
After transferring the preparation to the microscope, a further
thermistor was placed under the edge of the cremaster and
connected to the thermometer. All instruments were calibrated
before each experiment. The animal was allowed 30 min to equili-
brate before any experimentation, and temperature and blood pres-
sure were monitored at 5-min intervals initially and then every
15 min for the remainder ofthe experiment.
Experimental protocol
The animals were divided into five experimental groups (n = 5 in
each group):
group 1: host leucocytes and TCM
group 2: host leucocytes and FCM
group 3: LAK cells and TCM
group 4: LAK cells and FCM
group 5: LAK cells and CM.
During the equilibration period areas of interest were selected
within the cremaster muscle that could be clearly visualized using
transmitted and fluorescent light and were used to estimate the
numbers of host leucocytes and ex vivo-activated lymphocytes
interacting with the microcirculation. The vessels studied were
arterioles in the range 10-30 [lm, venules in the range 30-40 [tm
and post-capillary venules < 5 iim. One vessel of each category
was identified in each cremaster; thus measurements were taken
from three vessels from each preparation.
Following the equilibration period, 0.2 ml ofacridine red (1 mg
ml-'), labelled host leucocytes (groups 1 and 2) or LAK cells
labelled fluorescently ex vivo with acridine red (1 x 106; groups 3,
4 and 5) were injected intra-arterially; sixty minutes later, serum-
free TCM from the murine melanoma cell line (groups 1 and 3),
serum-free FCM from the 3T3 fibroblasts (groups 2 and 4) or
Table 1 Effects of tumour-conditioned, fibroblast-conditioned and complete media on lymphokine-activated killer cells and host leucocytes in a
venule in the cremaster muscle
0-60 min 75 min 75-120 min 120180 min
R cells A cells R cells A cells R cells A cells R cells A cells
LAK/TCM 2 1 6* 11* 4 1 3 1
0-4 1-2 4-12 8-14 3-6 0-4 2-6 0-3
HLUTCM 22 1 22 1 30* 6* 35* 5*
10-36 0-4 6-27 0-6 20-64 0-15 25-64 0-10
LAK/CM 2 1 1 1 0 1 0 1
0-2 0-1 0-2 0-2 0 0-1 0 0-1
LAK/FCM 3 0 3 1 2 0 1 0
2-9 0-1 2-9 0-1 2-6 0 2-6 0-1
HUFCM 21 2 20 2 20 1 23 1
10-36 0-3 11-26 1-3 11-30 1-2 11-30 1-2
Data represent median and range. *P< 0.05 vs control using Wilcoxon.
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Figure 1 The number of adherent host leucocytes (2) and LAK cells (E) in
response to topical application of tumour-conditioned medium to the
cremaster muscle at 60 min. Data are presented as median with the range
indicated above the bar; n = 5 in each group
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Figure 2 The number of rolling host leucocytes (&) and LAK cells (E) in
response to topical application of tumour-conditioned medium to the
cremaster muscle at 60 min. Data are presented as median with the range
indicated above the bar; n= 5 in each group
Table 2 Effects oftumour-conditioned, fibroblast-conditioned and complete media on lymphokine-activated killer cells and host leucocytes in an
arteriole in the cremaster muscle
0-60 min 75 min 75-120 min 120-180 min
R cells A cells R cells A cells R cells A cells R cells A cells
LAK/TCM 1 1 1 3* 1 1 1 1
0-2 0-1 0-2 1-5 0-2 0-3 0-2 0-2
HL/TCM 1 0 1 0 0 0 8* 3*
0-2 0-1 0-1 0 0-1 0 5-15 1-5
LAK/CM 1 0 1 0 0 1 0 1
0-2 0-1 0-2 0-2 0 0-1 0 0-1
LAK/FCM 1 0 0 0 0 0 1 0
0-1 0 0-1 0 0-1 0 0-1 0-1
HL/FCM 0 0 0 0 0 0 1 0
0 0 0-1 0 0-1 0 0-1 0
Data represent median and range. *P< 0.05 vs control using Wilcoxon.
serum-free culture medium (CM; group 5) was administered topi-
cally in a volume of 50 p1 to the area of interest on the cremaster
muscle.
Data collection and image analysis
Fluorescently labelled cells were subdivided into three categories:
1 no contact with the vessel wall - 'flyers';
2 adherent to but moving along the vessel wall - 'rollers';
3 adherent and stationary within the vessel - 'stickers'.
Measurements were taken for 1 min every 10 min for the 3-h
duration of the study. Vessel diameters were measured using
computerized image analysis, calibrated to produce values in
microns, and vessel flow was assessed qualitatively. Numbers of
fluorescently labelled cells in the different categories were
counted over the minute recording.
Statistical analysis
Numbers of cells per 250-[rm vessel length per minute were
expressed as median and range. Wilcoxon signed-rank test for
non-parametric data was used to analyse paired data (within group
comparison), and the Mann-Whitney U-test for non-parametric
data was used to analyse unpaired data (between group compar-
ison). Results were considered statistically significant at P < 0.05.
RESULTS
White cell trafficking
Venules
There was a significant increase in the frequency of rolling (P <
0.05) and adherent (P < 0.05) LAK cells immediately following
topical administration of TCM to the cremaster muscle (Table 1
and Figure 1). This increase was transient and had returned to
pretreatment values in both groups by the end of the experiment
(180 min).
There was a significant increase in the frequency ofboth rolling
(P < 0.05) and adherent (P < 0.05) host leucocytes but not until
90-120 min after topical administration of TCM to the cremaster
muscle (Table 1 and Figure 2). This was sustained for the
remainder ofthe experiment.
British Journal ofCancer (1997) 75(7), 993-999
CO
a)
c
-
ce
a
C
a)
IL
0CancerResearchCampaign 1997Leucocyte interactions with the microcirculation 997
0-
x
0
75
68
61
54
46
39
32
25
18
11
4
50:1 25:1 12:1 6:1
Effector -target ratio
Figure 3 The percentage cytotoxicity of in vitro-generated lymphokine-
activated killer cells (effector cells) against a variety of target cells: 0, P815;
*, YAC1; and V K1735
There was no alteration in the total number of cells (flying,
rolling and adherent) following administration of TCM in either
the LAK cell group (median 25,range 18-40) orthe hostleucocyte
group (median 70, range 60-94) forthe duration ofthe experiment
(180 min).
Topical administration of FCM or serum-free culture medium
had no effect on the frequency of rolling, adherent or the total
frequency ofLAK cells or host leucocytes in the venules.
Arterioles
There was a significant increase in the frequency ofadherent LAK
cells (P < 0.05) immediately following topical administration of
TCM to the cremaster muscle (Table 2 andFigure 1). This increase
was transient and had returned to pretreatment values by the end of
the experiment.
There was a significant increase in the frequency ofboth rolling
(P < 0.05) and adherent (P < 0.05) host leucocytes 2 h aftertopical
administration of TCM to the cremaster muscle (Table 2 and
Figure 2). This was sustained for the remainder ofthe experiment.
There was no alteration in the total number of cells (flying,
rolling and adherent) following administration of TCM in either
the LAK cell group (median 30,range 20-50) orthe hostleucocyte
group (median 65,range 60-80) forthe duration ofthe experiment.
Topical administration of FCM or serum-free culture medium
had no effect on the frequency of rolling, adherent or the total
frequency ofLAK cells or host leucocytes in the arterioles.
Capillaries
There was a significant increase in the frequency of rolling LAK
cells (P < 0.05) immediately after topical administration of TCM
to the cremaster muscle (TCM vs noTCM; median 2,range 0-3 vs
median 1, range 0-1; P < 0.05). This increase was transient and
had returned to pretreatment values by the end of the experiment.
There were no differences observed in the number of adherent
LAK cells within the capillaries.
There was a significant increase in the frequency ofboth rolling
(TCM vs no TCM; median 10, range 8-15 vs median 18, range
16-22; P < 0.05) and adherent (TCM vs no TCM; median 0, range
0-1 vs median 2, range 1-4; P < 0.05) host leucocytes 2 h after
topical administration of TCM to the cremaster muscle. This was
sustained for the remainder ofthe experiment.
There was no alteration in thetotal numberofcells (flying,rolling
and adherent) following administration of TCM in either the LAK
cell group (median 10, range 3-20) or the host leucocyte group
(median 32,range 3-40) for the remaining 2 h ofthe experiment.
Topical administration of FCM or serum-free culture medium
had no effect on the frequency of rolling, adherent or the total
frequency ofLAK cells or host leucocytes in the capillaries.
Cytotoxicity assay
Culture of splenocytes with IL-2 (LAK cells) resulted in an
increased cytotoxicity towards YACI, P815 and K1735 targets. A
typical response is shown in Figure 3 in which LAK cytotoxicity
against YACl was 51.1 + 6.2%, against P815 was 38.3 ± 3.7%
and against K1735 was 32 + 3.2%, using an effector-target cell
ratio of 50:1.
Physiological parameters
The heart rate, blood pressure and body temperature ofall animals
remained constant throughout the experimental period. Mean
arterial pressure was 100 ± 19 mmHg, and the mean pulse rate was
467 ± 50 beats per min. Body temperature, as measured by the
oesophageal thermocouple, was within the range 36.3-37.2°C.
There were no alterations in blood flow throughout the studies, as
assessed qualitatively.
DISCUSSION
The major observations of these studies were the transient and
immediate increase in LAK endothelial cell interactions and the
subsequent but sustained increase in host leucocyte-endothelial
cell interactions in response to topical application of tumour-
conditioned medium (TCM) from the murine melanoma cell line
K1735 to the normal cremaster muscle microcirculation. These
interactions were characterized by increased numbers of cells
rolling along and adhering to the endothelium. The administration
of medium from a non-tumour cell line (fibroblast-conditioned
medium, FCM) had no effects on leucocyte migration or adhesion,
suggesting the presence of one or more soluble tumour-specific
chemoattractants for leucocytes in the tumour-conditioned
medium. The increased interaction of both LAK cells and host
leucocytes to the endothelium occurred in all vessel types -
venules, arterioles and capillaries - although the greatest responses
were observed in the venules. The effect of topical application of
TCM and FCM on host leucocyte, as well as LAK cell recruitment
to the cremaster muscle, was studied as host leucocytes may play
an additional role in tumour rejection. It has been shown previ-
ously that the number of leucocyte-endothelium interactions
appears to be dependent on the leucocyte subpopulation being
observed (Sasaki et al, 1991; Fukumura et al, 1995).
Many studies have attempted to elucidate the mechanisms of
lymphocyte-mediated cytotoxicity and motility in vitro (Ratner
and Heppner, 1986; Goldfarb, 1989). However, few studies have
attempted to investigate the migration and localization of adop-
tively transferred activated lymphocytes orhost leucocytes into the
tumour environment or surrounding normal tissue using dynamic
visualization techniques, such as in vivo microscopy (Sasaki et al,
1991; Fukumura et al, 1995; Melder et al, 1995). Thus, the mecha-
nisms by which LAK cells and host immune cells are attracted to
the tumour and then promote tumour necrosis remain unclear;
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however, several possibilities exist. They may interact directly
with and lyse the tumour cells. They may induce cytokine release,
initiating tumour and endothelial cell damage, resulting in shut-
down of the tumour microcirculation; this may promote the
extravasation of other immune effector cells and/or result in
hypoxic regions within the tumour. It is not known how many
effector cells are required to either directly or indirectly lyse
tumour cells, but if this leucocyte-mediated tumour cell killing
requires the direct contact of effector cells with the tumour cells
then the ratio may be important. However, ifeffector cells damage
the endothelium then large numbers of tumour cells may be
destroyed indirectly and the tumour-effector cell ratio may be less
important. The cytotoxicity assay results demonstrate the ability of
the LAK cells to induce a non-specific cytotoxicity to the three
tumour cell lines in vitro, the most sensitive being YAC1.
LAK cells may also play an important role in promoting host
cytotoxic T-lymphocyte (CTL) responses to tumour antigens, and
recent evidence confirms that a variety of human malignancies
express tumour antigens capable of stimulating antigen-specific
MHC-restricted cytotoxic T lymphocytes (Brasseur et al, 1992;
van der Bruggen et al, 1991). Thus, indirect cytotoxic effects may
occur through LAK cells secreting a number of agents, including
growth-inhibitory cytokines and chemokines which recruit or acti-
vate host cytotoxic effector cells (Hiserodt and Chambers, 1988;
Mclntyre et al, 1992).
The results from this study demonstrate a transient increase in
contact of the LAK cells with the endothelium, immediately after
topical administration of TCM to the normal cremaster muscle.
These LAK cell-endothelium interactions lasted about 15-20 min,
but there was no response during this time by the host leucocytes.
The increased LAK interactions with the vascular endothelium
were immediate and short-lived; however, ifmedium was topically
applied for a second time, an increase in adhesion was again
observed. However, 90-120 min after TCM administration to the
normal cremaster muscle, there was a dramatic increase in the
numbers of host leucocytes interacting with the endothelium, i.e.
rolling and adhering. The observed time difference in increased
endothelial interactions between the two effector cell subtypes
suggest that the responses are mediated via different mechanisms.
However, both responses may be due to the presence ofcytokines
or chemokines in the tumour-conditioned medium (e.g. tumour
necrosis factoralpha,TNF-a) stimulating eitherrecruitment and/or
activation ofLAK cells and hostleucocytes, as has beenpreviously
discussed. Cytokines/chemokines may also induce up-regulation
of the adhesion molecules involved in leucocyte-endothelium
interactions.
The recruitment of leucocytes is thought to be a multistep
process. There is initial contact ortethering to the endothelium and
then rolling, followed by firm adhesion and transmigration. Most
rolling host leucocytes are probably granulocytes (Fiebig et al,
1991), but it is difficult to distinguish the different classes of
mononuclear cells using in vivo microscopy. Leucocyte rolling is
regulated by a class of adhesion molecules known as selectins
(Bevilacqua and Nelson, 1993). L-selectin is expressed on mono-
cytes, granulocytes and most lymphocytes, E-selectin is induced
on cytokine-treated endothelial cells and P-selectin is expressed on
stimulated and cytokine-treated platelets and endothelial cells
(Springer, 1995). In vitro studies have demonstrated that vascular
cell adhesion molecule-l (VCAM-1), P-, E- and L-selectin are
all involved in leucocyte rolling, but P- and E-selectin appear to
be the most important in lymphocyte rolling (Springer, 1995).
However, in vivo studies have demonstrated a role for P- and L-
selectin but not E-selectin in mouse leucocyte rolling, during
trauma and cytokine stimulation (Ley et al, 1995). Furthermore,
tumours are known to produce cytokines such as interleukin 1 (IL-
1) and TNF-a. TNF-a has been shown in previous studies to facil-
itate the binding of leucocytes to both normal and tumour
endothelium (Fukumura et al, 1995; Ley et al, 1995). This is due
to the up-regulation of adhesion molecules, such as E-selectin, P-
selectin, ICAM-1 and VCAM-1, on both leucocytes and endo-
thelium (Springer, 1995). Therefore, it is possible that the presence
of TNF-a in the TCM would induce increased expression of
both the integrins and selectins involved in leucocyte endothelial
binding.
Although the dorsal skin and cranial chamber models have been
used to study both normal and tumour vasculature as well as
leucocyte-endothelial interactions (Wu et al, 1994; Fukumura et
al, 1995), it is difficult to determine the mechanism of the
response. The tumour environment is already releasing cytokines
and chemokines, and so exogenous addition of these to the
chamber (which has proved to be technically difficult; Fukumura
et al, 1995) may not induce further interactions. In addition, it is
only possible to observe the surface vessels ofthe tumour in vivo.
The mouse cremaster muscle preparation is a modification of the
original ratpreparation (Baez, 1973; Meininger et al, 1987), which
has been extensively used in the field ofmicrocirculatory research.
The mouse preparation can be prepared for in vivo microscopy
(IVM) with an intact neurovascular supply; it is a thin preparation
(50-iim) with one layer of vessels, it has a superior resolution for
IVM and host leucocytes can be observed without fluorescent
labelling. Previous studies have used the rat cremaster muscle
microcirculation to demonstrate increased macromolecular
leakage of fluorescently labelled albumin in response to human
malignant ascites (Heuser et al, 1988; White et al, 1988). Thus,
changes in vascular permeability, which are important in tumour
biology, can also be measured using this model.
In summary, tumour-conditioned medium topically adminis-
tered to the mouse cremastermuscle induces increased adhesion of
both adoptively transferred LAK cells and host leucocytes. This is
a tumour-specific response as fibroblast-conditioned medium and
culture medium did not induce any changes in leucocyte behav-
iour. The present study also demonstrates that the mouse cremaster
muscle microcirculation is a useful model for investigating leuco-
cyte-endothelium interactions in response to those cytokines and
chemokines that are important in tumour biology. Characterization
of lymphocyte trafficking within the microcirculation and subse-
quent lymphocyte-endothelial cell interaction is a prerequisite for
understanding the mechanism of, and the low response rate
following, adoptive immunotherapy and may aid the design of
more successful treatment strategies to optimize the efficacy of
this treatment modality.
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